Market Tracker

10/22 6:05pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

25.92
Data as of Oct 22
 -0.85 / -3.18%
Today’s Change
15.64
Today|||52-Week Range
32.00
+3.72%
Year-to-Date

Today’s Trading

Previous close26.77
Today’s open26.82
Day’s range25.87 - 27.14
Volume1,035,421
Average volume (3 months)1,198,397
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-96.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book13.39

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+0.92+2.51%
WXWuxi Pharmatech Caym...-0.13-0.36%
--Cosmo Pharmaceutical...-11.95-6.38%
AVNRAvanir Pharmaceutica...-0.13-1.10%
Data as of 4:03pm ET, 10/22/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts